indirubin-3'-monoxime and paclitaxel

indirubin-3'-monoxime has been researched along with paclitaxel in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Chen, X; Goto, M; Lai, F; Lee, KH; Xiao, Z; Yan, L; Zhou, A1
Chen, BB; Chen, XB; Deng, WY; Han, LL; Li, N; Lü, HF; Luo, SX; Wang, XF1

Other Studies

4 other study(ies) available for indirubin-3'-monoxime and paclitaxel

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds.
    Bioorganic & medicinal chemistry letters, 2017, 08-01, Volume: 27, Issue:15

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Immunohistochemistry; Indoles; Molecular Structure; Structure-Activity Relationship

2017
Molecular mechanism of indirubin-3'-monoxime and Matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line.
    Chinese medical journal, 2013, Volume: 126, Issue:5

    Topics: Alkaloids; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Indoles; Inhibitor of Apoptosis Proteins; Matrines; Octamer Transcription Factor-3; Oximes; Paclitaxel; Quinolizines; SOXB1 Transcription Factors; Survivin

2013